Nickerson Joan

2.4

2.4

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Verve Therapeutics Inc (VERV)

Transaction date 2 Apr 2025

Sale

Price

392.68

Quantity 62,209 -28.7%

Value US$2,668,601

Comments Filing

Verve Therapeutics Inc (VERV)

Transaction date 2 Apr 2024

Sale

Price

357.84

Quantity 11,277 -11.1%

Value US$2,554,057

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-04-03	2025-04-02	Verve Therapeutics Inc (VERV)	S Sale	62,209 -28.7% 392.68 US$2,668,601	62,209 -28.7%	392.68	US$2,668,601
2024-04-03	2024-04-02	Verve Therapeutics Inc (VERV)	S Sale	11,277 -11.1% 357.84 US$2,554,057	11,277 -11.1%	357.84	US$2,554,057